Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer

New diagnostic division will acquire, invest in, and develop a portfolio of diagnostic solutions for the screening, diagnosis, and management of lung cancer. MENLO PARK, Calif., March 29, 2024 /PRNewswire/ — Maverix Medical, a dedicated lung cancer platform established by Ajax Health,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks